MIrabegron and Physiological Function in Cold Environments

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 19, 2023

Primary Completion Date

April 23, 2024

Study Completion Date

April 23, 2024

Conditions

Resting Energy ExpenditureThermogenesisBrown Adipose Tissue

Interventions

DRUG

Mirabegron

Dose-response effect on thermogenesis

DRUG

Placebo

Placebo control condition

Trial Locations (1)

Indiana University, Bloomington

All Listed Sponsors

collaborator

Office of Naval Research (ONR)

FED

lead

Indiana University

OTHER